© 2021 MJH Life Sciences and AJMC. All rights reserved.
© 2021 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
December 12, 2019
Implementing a claims-based algorithm and disease management program may be an effective strategy to reduce relapse and cost among patients with schizophrenia.
July 12, 2019
June 27, 2017
Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.
November 19, 2013
A large proportion of opioid analgesic treated chronic pain patients exhibited behaviors indicative of potentially problematic opioid use, which significantly affected healthcare costs.